CoChat

Burden of illness of bilateral neovascular age-related macular degeneration in Spain

María Ruiz-Moreno, José, María Coco, Rosa, García-Arumí, José, Xu, Xiao, Zlateva, Gergana · 2008 · Current Medical Research and Opinion

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The burden of illness, including health resource utilization and costs associated with bilateral neovascular age-related macular degeneration (Nv-AMD), was assessed in Spain. PATIENTS AND METHODS: As part of an international prospective, case-controlled study, 89 Spanish patients with bilateral Nv-AMD were recruited by retina specialists and 96 Spanish control subjects were recruited by general practitioners and ophthalmologists. Physicians recorded clinical data and visual acuity (VA). In a subsequent telephone interview, Nv-AMD patients and controls completed the National Eye Institute Visual Function Questionnaire (NEI VFQ)-25, the EuroQol (EQ-5D), and the Hospital Anxiety and Depression Scale (HADS) questionnaire. Annual vision-related and non-vision-related medical costs and non-medical-related costs were calculated from study-specific questions. RESULTS: The mean age was 76.2 years for Nv-AMD patients and 61.9 years for control subjects. The adjusted mean (95% CI) NEI VFQ-25 summary score was 51.9 (48.5; 55.4) for Nv-AMD patients and 87.7 (85.5; 89.9) for control subjects (p<0.05). The summary score of Nv-AMD patients decreased significantly with VA declination. Mean direct vision-related medical and non-medical-related costs were significantly greater for Nv-AMD patients than the control subjects, whereas non-vision-related medical costs were similar between groups. The total mean annual resource utilization cost was euro5733 for Nv-AMD patients compared to euro1070 for control subjects (p<0.0001). CONCLUSIONS: Although the study design is subject to a number of limitations, patients with Nv-AMD in Spain have worse quality of life outcomes, greater depression, and higher healthcare costs as compared with similarly-aged individuals who are not affected by this disease.

Overview

Integrity signals

Registry

Crossref · 10.1185/03007990802214300

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 24 references

Research works printed but not linked: 3

  1. Maguire MG, 1999, Natural history, 17
  2. Seddon JM, 2001, Retina, 1039
  3. SOIKOS, 2005, Base de datos de costes sanitarios. Version 2.2

Cited by

See all 37

Metadata

Authors
María Ruiz-Moreno, J., María Coco, R., García-Arumí, J., Xu, X., & Zlateva, G.
Affiliations
  • University of Castilla La Mancha, Albacete, Spain
  • Instituto de Oftalmobiología Aplicada (IOBA), Universidad de Valladolid, Valladolid, Spain
  • Hospital Vall d’Hebrón, Barcelona, Spain
  • Covance Market Access Services Inc, Gaithersburg, Maryland, USA
  • Pfizer (United States) (US)
Venue
Current Medical Research and Opinion
Published
2006-06-10
Volume
24
Issue
7
Pages
2103-2111
ISSN
  • 0300-7995 (ISSN-L)
  • 1473-4877
OpenAlex
W2017089824
Cited by
36
References
24
Citations by year
2026: 1 · 2025: 4 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 5 · 2014: 2 · 2013: 4 · 2012: 1
FWCI
0.00
Type
journal article
Language
en
Open access
closed
Locations
  • Current Medical Research and Opinion (publishedVersion)
  • PubMed (publishedVersion)
Funders
Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
Keywords
neovascular age-related macular degeneration, bilateral disease, disease burden, quality of life, visual function, visual acuity loss, health care costs, health resource utilization, depression, anxiety, Spain
MeSH terms
Aged, Aged, 80 and over, Female, Humans, Interviews as Topic, Macular Degeneration, Male, Middle Aged, Quality of Life, Spain, Visual Acuity, Case-Control Studies, Health Care Costs, Cost of Illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Burden of illness of bilateral neovascular age-related macular degeneration in Spain. https://app.cochat.ai/papers/10.1185/03007990802214300
The paper
María Ruiz-Moreno, J., María Coco, R., García-Arumí, J., Xu, X., & Zlateva, G. (2008). Burden of illness of bilateral neovascular age-related macular degeneration in Spain. Current Medical Research and Opinion. https://doi.org/10.1185/03007990802214300

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.